Access the full text.
Sign up today, get DeepDyve free for 14 days.
References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.
For many years I have followed the various vaccine and chemical treatments for chronic sinusitis. The vaccines have been used both hypodermically and locally as a filtrate with disappointing results. Every new treatment from the Carrel-Dakin down to the recent treatment with sulfanilamides and azosulfamide solutions has been used in the sinuses, and while the 2.5 per cent solution of azosulfamide used as a spray in the nose and throat has been giving favorable results in infections of acute involvement, such as in the recent epidemic of influenza, and apparently is a preventive to a certain extent in this infection, no results were obtained with it in the treatment of chronic infections of the sinuses. Cultures taken of material from the sinus in many cases of chronic sinusitis over a long period have shown that the predominating organism is the staphylococcus, so that when sulfamethylthiazole was introduced it seemed especially
JAMA – American Medical Association
Published: Apr 26, 1941
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.